Proton pump inhibitors and cardiovascular adverse events: a meta-analysis of randomized controlled trials

Some observational studies suggest a cardiovascular risk from proton-pump inhibitor (PPI) treatment, but observational data may be subject to bias. We conducted a meta-analysis of randomized controlled trial data on cardiovascular events during PPI treatment.